You are here: Industry Insights > Aleor

News List

Alembic Pharmaceuticals’s joint venture Aleor Dermaceuticals receives US FDA final approval for Mupirocin Cream USP, 2% ExpressPharma
November 19, 2021
Alembic Pharmaceuticals yesterday announced that its joint venture Aleor Dermaceuticals (Aleor) has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA)...
Aleor Dermaceuticals gets USFDA nod for Testosterone Topical Solution expresspharma
June 18, 2021
It is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism and Hypogonadotropic hypoqonadisrn.
Aleor Dermaceuticals gets tentative USFDA approval for Efinaconazole Topical Solution expresspharma
April 09, 2021
It is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.
Aleor Dermaceuticals gets USFDA nod for Nystatin and Triamcinolone Acetonide Cream expresspharma
April 02, 2021
Alembic Pharmaceuticals announced that its joint venture Aleor Dermaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Nystatin and Triamcinolone Acetonide Cream USP ...
Aleor Dermaceuticals gets USFDA Final nod for Testosterone Gel expresspharma
March 04, 2021
Testosterone Gel is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.